<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001264783</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001645113</issuerCik>
            <issuerName>NovoCure Limited</issuerName>
            <secFileNumber>001-37565</secFileNumber>
            <issuerAddress>
                <ns2:street1>No. 4 The Forum Grenville Street</ns2:street1>
                <ns2:city>St. Heiler</ns2:city>
                <ns2:stateOrCountry>Y9</ns2:stateOrCountry>
                <ns2:zipCode>JE2 4UF</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>4401534756700</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>WILHELMUS C. GROENHUYSEN</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>266085</noOfUnitsSold>
            <aggregateMarketValue>7929333.00</aggregateMarketValue>
            <noOfUnitsOutstanding>108201434</noOfUnitsOutstanding>
            <approxSaleDate>01/02/2025</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>01/02/2025</acquiredDate>
            <natureOfAcquisitionTransaction>Exercise of Stock Options</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>266085</amountOfSecuritiesAcquired>
            <paymentDate>01/02/2025</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <remarks>The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.&#13;
</remarks>
        <noticeSignature>
            <noticeDate>01/02/2025</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>06/05/2024</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Wilhelmus Groenhuysen</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3570}]
144
0001264783
XXXXXXXX
LIVE
0001645113
NovoCure Limited
001-37565
No. 4 The Forum Grenville Street
St. Heiler
Y9
JE2 4UF
4401534756700
WILHELMUS C. GROENHUYSEN
Officer
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
266085
7929333.00
108201434
01/02/2025
NASDAQ
Common
01/02/2025
Exercise of Stock Options
Issuer
N
266085
01/02/2025
Cash
Y
The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
01/02/2025
06/05/2024
/s/ Wilhelmus Groenhuysen